Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers

International Journal of Cancer

Volumn 140, Issue 12, 2017, Pages 2648-2656

  Keum, NaNa ^a   Yuan, Chen ^a,b   Nishihara, Reiko ^a,b,c   Zoltick, Emilie ^a   Hamada, Tsuyoshi ^b   Martinez Fernandez, Alejandro ^b   Zhang, Xuehong ^c   Hanyuda, Akiko ^a   Liu, Li ^a,b,d   Kosumi, Keisuke ^b   Nowak, Jonathan A ^c   Jhun, Iny ^c   Soong, T Rinda ^c   Morikawa, Teppei ^e   Tabung, Fred K ^a   Qian, Zhi Rong ^b   Fuchs, Charles S ^f   Meyerhardt, Jeffrey A ^b   Chan, Andrew T ^g   Ng, Kimmie ^b   Ogino, Shuji ^a,b,c   Giovannucci, Edward L ^a,c   Wu, Kana ^a   more..

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e UNIVERSITY OF TOKYO   (Japan)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

colorectal cancer; colorectal cancer survival; FASN; glycemic index; glycemic load; insulin index; insulin load; insulin signaling pathway; PIK3CA

Indexed keywords

B RAF KINASE; CTNNB1 PROTEIN; FASN PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; TUMOR MARKER; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; INSULIN;

AGED; ARTICLE; BRAF GENE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENE; GENE EXPRESSION; GENE MUTATION; GLYCEMIC INDEX; GLYCEMIC SCORE; HUMAN; INSULIN SCORE; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL PARAMETERS; ONCOGENE K RAS; PIK3CA GENE; PREDICTIVE VALUE; PROTEIN EXPRESSION; COLORECTAL TUMOR; DIET; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; METABOLISM; MULTIVARIATE ANALYSIS; MUTATION; NURSE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS;

BIOMARKERS, TUMOR; BLOOD GLUCOSE; COLORECTAL NEOPLASMS; DIET; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEALTH PERSONNEL; HUMANS; INSULIN; MALE; MULTIVARIATE ANALYSIS; MUTATION; NURSES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 85017129645     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30683     Document Type: Article

References (47)

1. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109S–20S.
2. Vigneri PG, Tirro E, Pennisi MS, et al. The insulin/IGF system in colorectal cancer development and resistance to therapy. Front Oncol 2015;5:230.
3. Lee J, Meyerhardt JA, Giovannucci E, et al. Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies. PloS One 2015;10:e0120706.
4. Van Blarigan EL, Meyerhardt JA. Role of physical activity and diet after colorectal cancer diagnosis. J Clin Oncol 2015;33:1825.
5. Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G. Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum 2013;56:1304–19.
6. Fung TT, Kashambwa R, Sato K, et al. Post diagnosis diet quality and colorectal cancer survival in women. PloS One 2014;9:e115377.
7. Ogino S, Chan AT, Fuchs CS, et al. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut, 2011;60:397–411.
8. Sul HS, Latasa MJ, Moon Y, et al. Regulation of the fatty acid synthase promoter by insulin. J Nutr 2000;130:315S–20S.
9. Nosho K, Kawasaki T, Ohnishi M, et al. PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. Neoplasia 2008;10:534–41.
10. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007;7:763–77.
11. Jones SF, Infante JR. Molecular pathways: fatty acid synthase. Clin Cancer Res Off J Am Assoc Cancer Res 2015;21:5434–8.
12. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, et al. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 2001;20:252–9.
13. Palsgaard J, Emanuelli B, Winnay JN, et al. Cross-talk between insulin and Wnt signaling in preadipocytes role of WNT co-receptor low density lipoprotein receptor-related protein-5 (LRP5). J Biol Chem 2012;287:12016–26.
14. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790−96.
15. Rimm EB, Giovannucci EL, Stampfer MJ, et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114–26; discussion 27–36.
16. Jenkins DJ, Wolever TM, Taylor RH, et al. glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981;34:362–6.
17. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 2002;76:5–56.
18. Holt SH, Miller JC, Petocz P. An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr 1997;66:1264–76.
19. Gannon MC, Nuttall FQ. Factors affecting interpretation of postprandial glucose and insulin areas. Diabetes Care 1987;10:759–63.
20. Giovannucci E. Glycemic index and colorectal carcinogenesis. Eur J Epidemiol 2004;19:405–7.
21. Moghaddam E, Vogt JA, Wolever TM. The effects of fat and protein on glycemic responses in nondiabetic humans vary with waist circumference, fasting plasma insulin, and dietary fiber intake. J Nutr 2006;136:2506–11.
22. Bhupathiraju SN, Tobias DK, Malik VS, et al. Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis. Am J Clin Nutr 2014;100:218–32.
23. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999;83:25F–9F.
24. Nimptsch K, Brand-Miller JC, Franz M, et al. Dietary insulin index and insulin load in relation to biomarkers of glycemic control, plasma lipids, and inflammation markers. Am J Clin Nutr 2011;94:182–90.
25. Ogino S, Kawasaki T, Brahmandam M, et al. Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn 2005;7:413–21.
26. Imamura Y, Lochhead P, Yamauchi M, et al. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Mol Cancer 2014;13.
27. Ogino S, Nosho K, Kirkner GJ, et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009;58:90–6.
28. Liao XY, Lochhead P, Nishihara R, et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 2012;367:1596–606.
29. Hanyuda A, Kim SA, Martinez-Fernandez A, et al. Survival benefit of exercise differs by tumor IRS1 expression status in colorectal cancer. Ann Surg Oncol 2016;23:908–17.
30. Ogino S, Nosho K, Meyerhardt JA, et al. Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol 2008;26:5713–20.
31. Ogino S, Brahmandam M, Cantor M, et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol Off J USCan Acad Pathol 2006;19:59–68.
32. Morikawa T, Kuchiba A, Yamauchi M, et al. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA J Am Med Assoc 2011;305:1685–94.
33. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the national death index. Am J Epidemiol 1984;119:837–9.
34. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563–72.
35. Fidler IJ. The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisited. Nat Rev Cancer 2003;3:453–8.
36. Wolpin BM, Meyerhardt JA, Chan AT, et al. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol 2009;27:176–85.
37. Cui G, Zhang T, Ren F, et al. High blood glucose levels correlate with tumor malignancy in colorectal cancer patients. Med Sci Monitor Int Med J Exp Clin Res 2015;21:3825–33.
38. Siddiqui AA, Spechler SJ, Huerta S, et al. Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Digest Dis Sci 2008;53:2486−2494.
39. Franz MJ. Protein: metabolism and effect on blood glucose levels. Diabet Educ 1997;23:643–6, 8, 50-1.
40. Nuttall FQ, Gannon MC. Metabolic response to egg white and cottage cheese protein in normal subjects. Metab Clin Exp 1990;39:749–55.
41. Nuttall FQ, Gannon MC. Plasma glucose and insulin response to macronutrients in nondiabetic and NIDDM subjects. Diabet Care 1991;14:824–38.
42. Godsland IF. Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci 2009;118:315–32.
43. Meric-Bernstam F, Gonzalez-Angulo AM. Targeting the mTOR signaling network for cancer therapy. J Clin Oncol 2009;27:2278–87.
44. Kuchiba A, Morikawa T, Yamauchi M, et al. Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. J Natl Cancer Inst 2012;104:415–20.
45. Lai K, Killingsworth MC, Lee CS. Gene of the month: PIK3CA. J Clin Pathol 2015;68:253–7.
46. Bao J, de Jong V, Atkinson F, et al. Food insulin index: physiologic basis for predicting insulin demand evoked by composite meals. Am J Clin Nutr 2009;90:986–92.
47. Ogino S, Nishihara R, VanderWeele TJ, et al. Review article: the role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine. Epidemiology 2016;27:602–11.